Valuation: Teva Pharmaceutical Industries Limited

Market Cap 45.77B 41.69B 38.42B 34.94B 65.56B 4,239B 68.9B 468B 186B 2,315B 172B 168B 7,266B P/E 2026 *
117x
P/E 2027 * 21.4x
Enterprise Value 57.75B 52.59B 48.46B 44.08B 82.7B 5,347B 86.92B 590B 234B 2,921B 217B 212B 9,166B EV / Sales 2026 *
3.44x
EV / Sales 2027 * 3.12x
Free-Float
91.3%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Teva Pharmaceutical Industries Limited

Manager TitleAgeSince
Chief Executive Officer 57 01/01/2023
Director of Finance/CFO 53 22/12/2019
Chief Operating Officer 52 03/06/2024
Director TitleAgeSince
Director/Board Member 70 01/01/2009
Chairman 78 06/02/2017
Director/Board Member 65 01/09/2015
Date Insider Type Main position Quantity % Market Cap. Importance
5/8/26 Sell

Director

-17 0.0000%
3/8/26 Exercice

Chief Technology Officer

131,066 0.0112%
3/8/26 Exercice

Head of Human Resources

38,481 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
+2.04%+2.01% - - 45.77B
-0.30%-6.68%+27.12%+127.32% 1,200B
+1.25%-5.35%+32.65%+78.98% 651B
+0.94%-2.99%+21.13%+106.30% 506B
-0.60%-1.95%+25.73%+67.00% 377B
+0.69%-9.50%+36.78%+30.83% 330B
+0.41%-4.70%+24.18%+50.18% 288B
+0.81%-4.08%-2.95%+31.59% 272B
-0.15%-6.45%+29.06%+65.76% 236B
-0.06%-0.98%+31.42%+122.83% 206B
Average +0.50%-4.76%+25.01%+75.64% 452B
Weighted average by Cap. +0.32%-5.19%+26.02%+87.88%

Financials

2026 *2027 *
Net sales 16.79B 15.29B 14.09B 12.82B 24.04B 1,555B 25.27B 171B 68.15B 849B 62.99B 61.66B 2,665B 17.35B 15.8B 14.56B 13.24B 24.85B 1,606B 26.11B 177B 70.43B 877B 65.09B 63.72B 2,754B
Net income 483M 440M 405M 368M 691M 44.69B 727M 4.93B 1.96B 24.41B 1.81B 1.77B 76.61B 2.2B 2B 1.85B 1.68B 3.15B 204B 3.31B 22.46B 8.93B 111B 8.25B 8.08B 349B
Net Debt 11.97B 10.9B 10.05B 9.14B 17.14B 1,108B 18.02B 122B 48.6B 605B 44.91B 43.97B 1,900B 8.36B 7.62B 7.02B 6.39B 11.98B 775B 12.59B 85.43B 33.96B 423B 31.38B 30.72B 1,328B
Logo Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
32,008
Trader
-
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Teva Pharmaceutical Industries Limited